<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Cutaneous lesions in <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) may be specific or not and may reveal bone marrow transformation </plain></SENT>
<SENT sid="1" pm="."><plain>Our purpose was to investigate in a cohort of 84 MDS patients the correlation of cutaneous findings with immunologic parameters and prognostic features of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> in order to clarify their potential clinical significance </plain></SENT>
<SENT sid="2" pm="."><plain>MATERIALS AND METHODS: We studied a cohort of 84 newly diagnosed <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients in order to assess the cutaneous findings present at the time of diagnosis and during 1 to 3 years of follow-up </plain></SENT>
<SENT sid="3" pm="."><plain>We described the clinical variety of cutaneous findings ascertained by histology </plain></SENT>
<SENT sid="4" pm="."><plain>We also looked for any association between the group of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients with skin manifestations and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> subtype, immunologic and prognostic features highlighting transformation to <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_336'>leukaemia</z:mpath> </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Twenty-one patients presented cutaneous manifestations: 1 patient developed <z:mpath ids='MPATH_336'>leukaemia</z:mpath> cutis, 6 patients <z:hpo ids='HP_0000992'>photosensitivity</z:hpo> not associated with <z:hpo ids='HP_0002960'>autoimmune disease</z:hpo>, 3 prurigo nodularis, 2 Sweet's syndrome, 6 leucocytoclastic <z:hpo ids='HP_0002633'>vasculitis</z:hpo>, 2 ecchymoses and <z:hpo ids='HP_0000979'>purpura</z:hpo> associated with preexisting <z:e sem="disease" ids="C0032453" disease_type="Disease or Syndrome" abbrv="">relapsing polychondritis</z:e>, 1 patient <z:hpo ids='HP_0001482'>subcutaneous nodules</z:hpo> associated with Wegener's <z:hpo ids='HP_0002955'>granulomatosis</z:hpo> and 1 patient with malar <z:e sem="disease" ids="C0015230" disease_type="Disease or Syndrome" abbrv="">rash</z:e> and <z:hpo ids='HP_0000155'>oral ulcers</z:hpo> associated with preexisting <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Adjusted for age and gender, the presence of skin findings constitutes a significant predictor of the high-risk <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> subgroup (odds ratio, 3.59; 95% confidence interval, 1.18-10.92) </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0010702'>Hypergammaglobulinemia</z:hpo> was significantly higher in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> subgroup with skin manifestations (P = 0.03) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: Most <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients with cutaneous manifestations belong to the high-risk <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> subgroup and present <z:hpo ids='HP_0010702'>hypergammaglobulinemia</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>Early biopsy of <z:mp ids='MP_0001212'>skin lesions</z:mp> in <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> is indicated </plain></SENT>
</text></document>